Five siRNAs targeting three SNPs in Huntingtin may provide therapy for three-quarters of Huntington’s disease patients

Among dominant neurodegenerative disorders, Huntington’s disease (HD) is perhaps the best candidate for treatment with small interfering RNAs (siRNAs) [1–9]. Invariably fatal, HD is caused by expansion of a CAG repeat in the Huntingtin gene, creating an extended polyglutamine tract that makes the Hu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pfister, Edith L., Kennington, Lori, Straubhaar, Juerg, Wagh, Sujata, Liu, Wanzhou, DiFiglia, Marian, Landwehrmeyer, Bernhard, Vonsattel, Jean-Paul, Zamore, Phillip D., Aronin, Neil
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2746439/
https://ncbi.nlm.nih.gov/pubmed/19361997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cub.2009.03.030
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados